EUVIMEDEUVIMED entdecken
Crossref

Comparing the Efficacy of Remdesivir, Favipiravir, and Casirivimab and Imdevimab on Duration of Hospitalization and ICU Stay of Hospitalized COVID-19 Patients

Sahar Kmal Hegazy, Ahmed Hosny Hassan

Life Science Research Communications · 2024

DOI: 10.5530/lsrc.1.1.7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Research Communications, 2024. Verfasst von Sahar Kmal Hegazy und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hegazy, S. K., & Hassan, A. H. (2024). Comparing the Efficacy of Remdesivir, Favipiravir, and Casirivimab and Imdevimab on Duration of Hospitalization and ICU Stay of Hospitalized COVID-19 Patients. Life Science Research Communications. https://doi.org/10.5530/lsrc.1.1.7

Vancouver

Hegazy SK, Hassan AH. Comparing the Efficacy of Remdesivir, Favipiravir, and Casirivimab and Imdevimab on Duration of Hospitalization and ICU Stay of Hospitalized COVID-19 Patients. Life Science Research Communications. 2024. doi:10.5530/lsrc.1.1.7

BibTeX
@article{Hegazy2024,
  author = {Hegazy, Sahar Kmal and Hassan, Ahmed Hosny},
  title = {Comparing the Efficacy of Remdesivir, Favipiravir, and Casirivimab and Imdevimab on Duration of Hospitalization and ICU Stay of Hospitalized COVID-19 Patients},
  journal = {Life Science Research Communications},
  year = {2024},
  doi = {10.5530/lsrc.1.1.7}
}
Kostenlos starten →